SOURCES SOUGHT
R -- Waiting Room-Delivered Video to Enhance Antiretroviral Therapy Readiness, Adherence, and Retention in Care for HIV-Positive Minority Persons
- Notice Date
- 4/4/2013
- Notice Type
- Sources Sought
- NAICS
- 541990
— All Other Professional, Scientific, and Technical Services
- Contracting Office
- Department of Health and Human Services, Centers for Disease Control and Prevention, Procurement and Grants Office (Atlanta), 2920 Brandywine Road, Room 3000, Atlanta, Georgia, 30341-4146
- ZIP Code
- 30341-4146
- Solicitation Number
- SNR56653
- Archive Date
- 5/4/2013
- Point of Contact
- Sherrie N. Randall, Phone: 7704882866, Teri M Routh-Murphy, Phone: 770-488-2713
- E-Mail Address
-
iom2@cdc.gov, tnr3@cdc.gov
(iom2@cdc.gov, tnr3@cdc.gov)
- Small Business Set-Aside
- N/A
- Description
- This is a sources sought announcement to determine the availability of potential vendors (including, but not limited to, GSA vendors under the Advertising and Integrated Marketing Solutions SIN 541-5 "Integrated Marketing Services", small business (e.g. 8 (a), veteran-owned small business, service-disabled veteran owned small business, HUBZone small business, small disadvantage business, and women-owned small business) that can provide support to the Division of HIV/AIDS Prevention (DHAP) to develop a waiting room-delivered video to enhance antiretroviral therapy (ART) readiness and adherence and retention in care for HIV-positive minority persons. Background: Research findings from the HIV Prevention Trials Network HPTN052 study published in 2011 concluded that HIV-positive men and women could reduce their risk of transmitting the virus to their sexual partners by 96% when taking oral antiretroviral therapy (ART). The ability of patients to initiate and adhere to a rigorous and complex ART treatment regime is challenging. There are many reasons for failing to initiate treatment or adhering to a precise and consistent medication schedule that is needed for treatment to be successful. Factors shown to influence treatment readiness and decrease adherence include a patient's comprehension of their HIV infection and treatment recommendations, health beliefs associated with the benefits of therapy, fears or ambivalence about starting treatment, dosing/regime barriers psychiatric/co-morbidity factors, and lack of social or provider support. The Centers for Disease Control and Prevention's (CDC) Compendium of HIV Prevention Interventions with Evidence of Effectiveness has identified 8 intervention programs that have demonstrated varying levels of efficacy for improving ART-related outcomes among HIV-positive persons. These programs included six educational/behavioral interventions to improve ART adherence, and two Directly Administered Antiretroviral Therapy (DAART) interventions. All of these interventions are delivered in individual- or small group-level formats and require considerable resources to implement and substantial time commitments from clients. As a result, there is a significant need for treatment readiness/adherence interventions that can be brought to scale quickly, provide maximum coverage, and be sustained at relatively little cost. The development of a video-based structural intervention through this contract directly supports CDC's High-Impact HIV Prevention framework. The Patient Protection and Affordable Care Act is poised to bring millions of uninsured people - including many HIV-infected minority persons - into the health care system when it is implemented in 2014. Clinical settings may be increasingly more dependent on adopting simple, low-cost, low-intensity waiting room delivered interventions, which can be administered with minimal staff time as part of routine clinical services, to supplement more intensive but effective interventions that require additional patient or staff time to implement. Stand-alone video-based interventions have been found to be efficacious, low-cost, and require limited staff time or training. The stand-alone video-based approach focusing on encouragement of ART among treatment-naïve patients and ART adherence among HIV-positive patients in treatment may prove to be an important prevention tool in achieving goals of the National HIV/AIDS Strategy, such as improving health outcomes for persons living with HIV/AIDS and reducing HIV-related disparities and health inequities. This video also could be a key product to assist CDC's prevention efforts with HIV-positives. In addition, this video will have broad applicability beyond CDC's DHAP and should be feasible, practical, and cost-effective to extend to virtually all medical care settings across the U.S. that provide HIV medical care to HIV-positive persons, including Health Resources and Services Administration-funded grantees, Veterans Administration-funded clinical care sites, and all private HIV treatment and care clinics. Purpose and Objectives: The purpose of this contract is to develop, beta-test, and refine a brief, video-delivered, waiting room intervention that promotes early initiation of ART among treatment-naïve HIV-positive patients, adherence to ART and retention in care among HIV-positive patients currently on therapy, sexual risk reduction tailored to HIV-positive persons, and patient-initiated discussion of these topics with their providers. Specific objectives of the contract include the following: 1. Develop a draft theory-based, brief, video-delivered waiting room intervention that promotes early initiation of ART among treatment-naïve clients, adherence to ART and retention in care among HIV-positive patients currently on therapy, and sexual risk reduction tailored to HIV-positive minority persons. 2. Develop "movie style" posters to enhance viewership and a User's Guide to improve the integration of the video into HIV/AIDS treatment facilities. 3. Conduct a beta-test of the draft video intervention in up to four HIV/AIDS treatment facilities meeting specific programmatic criteria. 4. Document the feasibility and use of this intervention during routine clinical care. 5. Collect observational data and supplemental patient-level medical record data from participating treatment facilities as part of the beta-test of the draft video intervention. 6. Refine the draft video intervention based on analysis of the patients' reactions. 7. Produce interim and final progress reports. 8. Create and deliver interim data sets and final data sets. The Vendor shall demonstrate capability with the following requirements: 1. Demonstrate evidence of prior collaboration with governmental or nongovernmental organizations including state and local health departments and other groups that provide HIV prevention and/or treatment services for HIV-positive African Americans and Hispanic/Latinos, including Men Having Sex With Men (MSM). 2. Demonstrate ability to design and produce a video-waiting room intervention for HIV/AIDS treatment facilities. 3. Demonstrate the ability to conduct beta-testing for a video-waiting room intervention. 4. Demonstrate the capacity to design, collect and manage electronic datasets from multiple facilities and the ability to ensure data safety. 5. Demonstrate evidence of ability to create and transfer interim and final data sets to customers. Capability Statement: Vendors who believe they have the ability to satisfy all of the above stated objectives are encouraged to submit a capability statement. The capability statements will be evaluated based on the information provided in relation to the objectives and requirements above and the current in-house capacity to perform the work including: (a) knowledge of staff availability, experience, and training; (b) prior completed projects of a similar nature; and (c) examples of prior completed contracts, dollar value of the contracts, references, and other related information. Capability statements shall include the following information: company name, address, point of contact, phone/fax/email, business size and status (e.g. small business, 8(a), veteran-owned small business, service-disabled veteran owned small business, HUBZone small business, small disadvantage business, and women owned small business) and current GSA Schedules under SIN 541-5, "Integrated Marketing Services". The remainder of the capability statement should be tailored to the information outlined in this Sources Sought Announcement and must demonstrate that similar work has been performed in the past. Submission Instructions: Interested parties having the capabilities necessary to perform the stated requirements may submit capability statement (maximum 10 pages) via email to Sherrie Randall (srandall@cdc.gov). The subject line of the email shall be "Antiretroviral Therapy ". Responses are due no later than April 19, 2013 by 12:00PM EST. Capability statements will not be accepted after the due date. Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. RESPONSES TO THIS NOTICE WILL NOT BE CONSIDERED ADEQUATE RESPONSES TO A SOLICITATION.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/CDCP/PGOA/SNR56653/listing.html)
- Record
- SN03028507-W 20130406/130404234452-5f2e904dcfb1584aa09e1c1c588101e1 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |